High Growth Tech Stocks In US With Promising Potential

The U.S. market has recently experienced mostly positive momentum, with major indices like the Nasdaq and S&P 500 showing gains following strong earnings reports from big tech companies such as Amazon. In this environment of optimism, investors often look for high growth potential in tech stocks that demonstrate robust fundamentals and innovative capabilities to capitalize on emerging trends.

Top 10 High Growth Tech Companies In The United States

Name Revenue Growth Earnings Growth Growth Rating Exelixis 10.58% 20.15% ★★★★★☆ Palantir Technologies 25.12% 31.65% ★★★★★★ Workday 11.20% 32.07% ★★★★★☆ RenovoRx 65.52% 68.63% ★★★★★☆ OS Therapies 56.64% 68.61% ★★★★★☆ Gorilla Technology Group 32.75% 122.61% ★★★★★☆ Circle Internet Group 27.53% 82.41% ★★★★★☆ Aldeyra Therapeutics 42.92% 73.80% ★★★★★☆ Vanda Pharmaceuticals 23.06% 68.52% ★★★★★☆ Zscaler 15.74% 40.94% ★★★★★☆

Click here to see the full list of 74 stocks from our US High Growth Tech and AI Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Arcturus Therapeutics Holdings

Simply Wall St Growth Rating: ★★★★★☆

Overview: Arcturus Therapeutics Holdings Inc. focuses on developing vaccines for infectious diseases and products targeting liver and respiratory rare diseases, with a market capitalization of $261.50 million.

Operations: Arcturus Therapeutics Holdings Inc. generates revenue primarily through the discovery, development, and commercialization of messenger RNA medicines, amounting to $122.12 million.

Arcturus Therapeutics Holdings, despite its current unprofitability, is demonstrating significant potential in the biotech sector with a forecasted annual revenue growth of 34.3%. This growth is substantially higher than the US market average of 10.3%. The company's commitment to innovation is evident in its recent advancements in mRNA therapy for cystic fibrosis, highlighted by promising interim results from its Phase 2 clinical trial of ARCT-032. With R&D efforts underscored by strategic presentations at major global conferences and an anticipated move towards profitability within three years, Arcturus represents a dynamic component within high-growth tech sectors focused on medical advancements.

Delve into the full analysis health report here for a deeper understanding of Arcturus Therapeutics Holdings. Evaluate Arcturus Therapeutics Holdings' historical performance by accessing our past performance report.ARCT Revenue and Expenses Breakdown as at Oct 2025

Intapp

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Intapp, Inc. offers AI-powered solutions globally through its subsidiary, Integration Appliance, Inc., and has a market capitalization of approximately $3.13 billion.

Continua a leggere

Operations: The company generates revenue primarily from its Software & Programming segment, which reported $504.12 million.

Intapp, navigating through a competitive tech landscape, has shown promising growth with a 12.1% annual revenue increase and an impressive earnings growth forecast of 107.6% per year. The company's strategic focus on R&D is evident from its substantial investment in this area, aligning with recent client engagements like Ostberg Sinclair & Co and Infinedi Partners to enhance their operational efficiencies through Intapp's advanced software solutions. These collaborations not only underscore Intapp’s commitment to innovation but also position it well for sustained growth amidst evolving market demands.

Dive into the specifics of Intapp here with our thorough health report. Gain insights into Intapp's past trends and performance with our Past report.INTA Earnings and Revenue Growth as at Oct 2025

Opera

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Opera Limited, along with its subsidiaries, offers mobile and PC web browsers and related products and services both in Norway and globally, with a market cap of $1.34 billion.

Operations: Opera generates revenue primarily through its mobile and PC web browsers, offering a range of related products and services internationally.

Despite a challenging year with a 49.1% decline in earnings, Opera is pivoting towards significant growth, forecasting an impressive 23.8% increase in annual earnings. This optimism is bolstered by their innovative strides in AI through the introduction of Opera Neon, an agentic browser that enhances user interaction with advanced AI capabilities. With recent revenue hitting $151.94 million for Q3 and an expected annual surge to $600 million, Opera's strategic investments in R&D are setting the stage for a transformative leap in browsing technology, potentially reshaping user engagement online.

Navigate through the intricacies of Opera with our comprehensive health report here. Review our historical performance report to gain insights into Opera's's past performance.OPRA Earnings and Revenue Growth as at Oct 2025

Make It Happen

Reveal the 74 hidden gems among our US High Growth Tech and AI Stocks screener with a single click here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Looking For Alternative Opportunities?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ARCTINTA and OPRA.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

Visualizza commenti